经颈静脉肝内门体分流术诱发的肝肺高血压病例报告。
A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.
机构信息
Department of Medicine, Cardiovascular Division, University of Minnesota, Minneapolis, MN.
Department of Medicine, Cardiovascular Division, University of Minnesota, Minneapolis, MN.
出版信息
Chest. 2021 Apr;159(4):e193-e196. doi: 10.1016/j.chest.2020.11.014. Epub 2021 Apr 6.
Abstract
We report here a case of portopulmonary hypertension following transjugular intrahepatic portosystemic shunt.
摘要
我们在此报告一例经颈静脉肝内门体分流术后发生的肝肺高血压。
相似文献
1
A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.经颈静脉肝内门体分流术诱发的肝肺高血压病例报告。
Chest. 2021 Apr;159(4):e193-e196. doi: 10.1016/j.chest.2020.11.014. Epub 2021 Apr 6.
2
Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.经颈静脉肝内门体分流术在门静脉高压症治疗中的作用。
Clin Liver Dis. 2014 May;18(2):319-34. doi: 10.1016/j.cld.2013.12.004.
3
Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.经颈静脉肝内门体分流术用于控制肝硬化患者门静脉高压并发症
World J Gastroenterol. 2014 Sep 7;20(33):11835-9. doi: 10.3748/wjg.v20.i33.11835.
4
Hepatic encephalopathy and survival after transjugular intrahepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?经颈静脉肝内门体分流术后的肝性脑病与生存：自发性门体分流起作用吗？
J Hepatol. 2024 Jun;80(6):e260-e261. doi: 10.1016/j.jhep.2023.12.014. Epub 2023 Dec 26.
5
[Transjugular intrahepatic portosystemic shunt in treatment of portal hypertension].经颈静脉肝内门体分流术治疗门静脉高压症
Khirurgiia (Mosk). 1999(7):64-9.
6
Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension.经颈静脉肝内门体分流术后使用覆膜支架治疗门静脉高压患者的良好临床转归。
J Hepatobiliary Pancreat Sci. 2010 Sep;17(5):701-8. doi: 10.1007/s00534-010-0270-8. Epub 2010 Mar 18.
7
Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.经颈静脉肝内门体分流术治疗肝硬化患者：适应证和 2020 年经颈静脉肝内门体分流术相关并发症。
United European Gastroenterol J. 2021 Mar;9(2):203-208. doi: 10.1177/2050640620952637. Epub 2021 Feb 23.
8
The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters.经颈静脉肝内门体分流术对全身心脏循环参数的影响。
J Crit Care. 2014 Dec;29(6):1001-5. doi: 10.1016/j.jcrc.2014.06.028. Epub 2014 Aug 16.
9
[Sufficiency in the reduction of the portosystemic pressure gradient by implantation of a second transjugular intrahepatic portosystemic shunt].[通过植入第二个经颈静脉肝内门体分流术降低门体压力梯度的充分性]
Rofo. 2013 Jul;185(7):666-8. doi: 10.1055/s-0033-1335139. Epub 2013 May 21.
引用本文的文献
1
Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.肝旁路在病原体相关肺血管疾病发展中的作用：中腔静脉分流和门体分流的影响
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G791-G800. doi: 10.1152/ajpgi.00409.2024. Epub 2025 May 5.
2
A rare case of idiopathic portal hypertension with portopulmonary hypertension occurred following splenectomy with a change in portal hemodynamics.脾切除术后发生门静脉血流动力学改变，进而出现罕见的特发性门静脉高压伴门静脉肺动脉高压病例。
Clin J Gastroenterol. 2025 Feb;18(1):130-136. doi: 10.1007/s12328-024-02072-0. Epub 2024 Dec 12.
3
Gut Microbiome and Pulmonary Arterial Hypertension - A Novel and Evolving Paradigm.肠道微生物组与肺动脉高压——一个新颖而不断发展的范式。
Physiol Res. 2024 Nov 29;73(S2):S477-S485. doi: 10.33549/physiolres.935430.
4
Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.肝和肺脉管系统的共有特征包括在宿主防御和炎症调节中可比的嘌呤能信号转导反应。
Am J Physiol Gastrointest Liver Physiol. 2021 Aug 1;321(2):G200-G212. doi: 10.1152/ajpgi.00406.2020. Epub 2021 Jun 9.
本文引用的文献
1
Transjugular Portosystemic Shunt Reductions: A Retrospective Single-Center Experience.经颈静脉门体分流术减少术：单中心回顾性经验。
J Vasc Interv Radiol. 2019 Jun;30(6):876-884. doi: 10.1016/j.jvir.2019.01.031.
2
Predictors of mortality after transjugular portosystemic shunt.经颈静脉肝内门体分流术后死亡的预测因素。
World J Hepatol. 2016 Apr 18;8(11):520-9. doi: 10.4254/wjh.v8.i11.520.
3
Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术患者长期随访中的心脏容量超负荷与肺动脉高压
Aliment Pharmacol Ther. 2016 May;43(9):955-65. doi: 10.1111/apt.13569. Epub 2016 Feb 26.
4
Transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术
Clin Liver Dis. 2014 Nov;18(4):853-76. doi: 10.1016/j.cld.2014.07.006. Epub 2014 Aug 27.
5
Pulmonary arterial hypertension combined with a high cardiac output state: Three remarkable cases.肺动脉高压合并高心输出量状态：三例显著病例。
Pulm Circ. 2013 Apr;3(2):440-3. doi: 10.4103/2045-8932.113185.
6
Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters.经颈静脉肝内门体分流术与二尖瓣流入参数的显著变化有关。
Ann Hepatol. 2013 May-Jun;12(3):464-70.
7
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.门脉高压性肺高血压和肝肺综合征：临床医生导向概述。
Eur Respir Rev. 2012 Sep 1;21(125):223-33. doi: 10.1183/09059180.00007211.
8
Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.特发性门腔分流在门肺高压患者中的流行情况及其对治疗的影响。
Gastroenterology. 2011 Nov;141(5):1673-9. doi: 10.1053/j.gastro.2011.06.053. Epub 2011 Jun 30.
9
A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.CD68(+) 巨噬细胞在肝肺综合征中起核心作用。巨噬细胞耗竭可逆转。
Am J Respir Crit Care Med. 2011 Apr 15;183(8):1080-91. doi: 10.1164/rccm.201008-1303OC. Epub 2010 Dec 10.
10
Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts (Abernethy type 2) by living donor liver transplantation after surgical shunt ligation.手术结扎分流术后，通过活体肝移植治疗先天性肝外门腔分流（Abernethy 型 2 型）引起的肺动脉高压获得成功。
Transpl Int. 2010 Jan;23(1):105-9. doi: 10.1111/j.1432-2277.2009.00964.x. Epub 2009 Sep 15.
Zotero 插件